VASH2 and pancreatic neoplasm: The proportion of specimens exhibiting middle/strong staining for VASH2 was significantly higher in pancreatic cancer tissue samples (56.9%, 58/102) than in adjacent normal tissue samples (24.5%, 25/102; P = 0.001).